Cargando…

Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer

BACKGROUND: Patients with curable esophageal cancer (EC) who proceed beyond the original Chemoradiotherapy for Oesophageal Cancer Followed by Surgery Study (CROSS) eligibility criteria are also treated with neoadjuvant chemoradiotherapy (nCRT). This study assessed the effect that extending the CROSS...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Heer, E. C., Hulshoff, J. B., Klerk, D., Burgerhof, J. G. M., de Groot, D. J. A., Plukker, J. Th. M., Hospers, G. A. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Gastrointestinal Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486922/ https://www.ncbi.nlm.nih.gov/pubmed/28188501 http://dx.doi.org/10.1245/s10434-017-5797-3

Ejemplares similares

Effect of Extending the Original CROSS Criteria on Tumor Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients: A National Multicenter Cohort Analysis
por: Wang, Helena Hong, et al.
Publicado: (2020)

Potential Predictive Immune and Metabolic Biomarkers of Tumor Microenvironment Regarding Pathological and Clinical Response in Esophageal Cancer After Neoadjuvant Chemoradiotherapy: A Systematic Review
por: Wang, H. H., et al.
Publicado: (2023)

Addition of HER2 and CD44 to (18)F-FDG PET–based clinico-radiomic models enhances prediction of neoadjuvant chemoradiotherapy response in esophageal cancer
por: Beukinga, Roelof J., et al.
Publicado: (2020)

Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy
por: Hulshoff, J. B., et al.
Publicado: (2015)

Extended Esophagectomy in Elderly Patients with Esophageal Cancer: Minor Effect of Age Alone in Determining the Postoperative Course and Survival
por: Pultrum, B. B., et al.
Publicado: (2010)

ASO Author Reflections: Pathologic Complete Response of Extended CROSS Criteria Patients with Esophageal Cancer
por: Wang, H. H., et al.
Publicado: (2020)

Prevalence and Prognostic Significance of Extramural Venous Invasion in Patients with Locally Advanced Esophageal Cancer
por: Faiz, Zohra, et al.
Publicado: (2018)

Better Survival in Patients with Esophageal Cancer After Surgical Treatment in University Hospitals: A Plea for Performance by Surgical Oncologists
por: Verhoef, Christian, et al.
Publicado: (2007)

Prediction of Non-Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients with (18)F-FDG PET Radiomics Based Machine Learning Classification
por: Beukinga, Roelof J., et al.
Publicado: (2022)

A Critical Appraisal of Circumferential Resection Margins in Esophageal Carcinoma
por: Pultrum, Bareld B., et al.
Publicado: (2009)

Magnetization transfer imaging to assess tumour response after chemoradiotherapy in rectal cancer
por: Martens, Milou H, et al.
Publicado: (2015)

Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma
por: Anderegg, M. C. J., et al.
Publicado: (2017)

Using the Comprehensive Complication Index to Assess the Impact of Neoadjuvant Chemoradiotherapy on Complication Severity After Esophagectomy for Cancer
por: Nederlof, Nina, et al.
Publicado: (2016)

Outcome of Patients Treated Within and Outside a Randomized Clinical Trial on Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: Extrapolation of a Randomized Clinical Trial (CROSS)
por: Toxopeus, Eelke, et al.
Publicado: (2018)

A Highly Active and Tolerable Neoadjuvant Regimen Combining Paclitaxel, Carboplatin, 5-FU, and Radiation Therapy in Patients with Stage II and III Esophageal Cancer
por: van de Schoot, L., et al.
Publicado: (2007)

Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study
por: Bisschop, C., et al.
Publicado: (2017)

Preoperative Chemoradiotherapy with Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer. A Phase I–II Multicenter Study of the Dutch Colorectal Cancer Group
por: Hospers, Geke A., et al.
Publicado: (2007)

MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated with organ preservation after chemoradiotherapy
por: Lambregts, Doenja M. J., et al.
Publicado: (2015)

Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy
por: Cheng, Xingyuan, et al.
Publicado: (2023)

Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy
por: Adusumilli, Pratik, et al.
Publicado: (2022)

Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy
por: Zhou, Xi‐Lei, et al.
Publicado: (2019)

How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer?
por: Jang, Jong Keon, et al.
Publicado: (2021)

Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
por: He, Wenwu, et al.
Publicado: (2022)

Boerhaave syndrome in an elderly man successfully treated with 3-month indwelling esophageal stent
por: Y, Kopelman, et al.
Publicado: (2018)

The presence of an asymptomatic aberrant right subclavian artery: A potential risk factor in esophageal surgery?
por: Chon, Seung-Hun, et al.
Publicado: (2017)

ASO Author Reflections: A Systematic Review on Predictive Immune and Metabolic Biomarkers to Predict Clinical and Pathological Response in Esophageal Cancer
por: Wang, H. H., et al.
Publicado: (2023)

Histological Regression of Squamous Esophageal Carcinoma Assessed by Percentage of Residual Viable Cells after Neoadjuvant Chemoradiation is an Important Prognostic Factor
por: Tong, Daniel King Hung, et al.
Publicado: (2010)

Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma
por: Moore, Jonathan L., et al.
Publicado: (2023)

Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma
por: Goedegebuure, R.S.A., et al.
Publicado: (2021)

Massive upper gastrointestinal bleeding caused by an intercostal arterio-esophageal fistula: A rare case report
por: Yang, Kai-Chun, et al.
Publicado: (2020)

Computer tomography colonography participation and yield in patients under surveillance for 6-9 mm polyps in a population-based screening trial
por: Tutein Nolthenius, Charlotte J., et al.
Publicado: (2015)

Omental herniation through the esophageal hiatus: A rare cause of gastric outlet obstruction and its CT findings
por: Tanaka, Yoshikazu, et al.
Publicado: (2020)

Massive Gastric Distension from Chronic Intestinal Pseudo-Obstruction
por: DeNazareth, Andrew G, et al.
Publicado: (2012)

FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review
por: Omloo, J. M. T., et al.
Publicado: (2011)

Response Assessment with MRI after Chemoradiotherapy in Rectal Cancer: Current Evidences
por: Seo, Nieun, et al.
Publicado: (2019)

The first joint ESGAR/ ESPR consensus statement on the technical performance of cross-sectional small bowel and colonic imaging
por: Taylor, S. A., et al.
Publicado: (2016)

High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy
por: Mitra, Devarati, et al.
Publicado: (2019)

Standardised reports with a template format are superior to free text reports: the case for rectal cancer reporting in clinical practice
por: Brown, P. J., et al.
Publicado: (2019)

Short-term changes observed in multiparametric liver MRI following therapy with direct-acting antivirals in chronic hepatitis C virus patients
por: Bradley, C., et al.
Publicado: (2018)

Liver CT for vascular mapping during radioembolisation workup: comparison of an early and late arterial phase protocol
por: van den Hoven, Andor F., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7889i6hmjfplu9rstgiintr7kf